We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick pickspolarean Share News (POLX)

Share Price Information for polarean (POLX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.80
Bid: 3.70
Ask: 3.90
Change: 0.00 (0.00%)
Spread: 0.20 (5.405%)
Open: 3.80
High: 3.80
Low: 3.80
Prev. Close: 3.80
POLX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Novacyt expands VersaLab with rapid Covid tests

Wed, 17th Mar 2021 14:44

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

Novacyt SA - Anglo-French biotechnology group focused on clinical diagnostics - Announces the expansion of its VersaLab service with the launch of mobile processing laboratories to provide rapid turnaround PCR testing for Covid-19 on-site. "Throughout the Covid-19 pandemic, Novacyt has focused on innovation to ensure we adapt in line with a rapidly evolving market. The roll-out of our VersaLab MPL units is an exciting development for Novacyt, as we continue to bring PCR technology outside of the central laboratory and closer to patients," says Chief Executive Graham Mullis.

----------

Oxford BioDynamics PLC - biotechnology firm focused on discovery and development of epigenetic biomarkers - Publishes results of biomarker discovery program for the development of EpiSwitch, a severity test for Covid-19. Says results show strong biological links to well-established and new regulatory pathways specific to severe outcomes in Covid-19 patients."EpiSwitch is a liquid biopsy technology that has consistently shown the strong and robust link between 3D genomic readouts and clinical outcomes. Our plans to launch the EpiSwitch Covid-19 Severity Test based on this groundbreaking biomarker discovery work by the end of Q1 2021, are on track." says Chief Executive Jon Burrows.

----------

Zenith Energy Ltd - oil & gas company with production, exploration and development assets in Africa and Italy - Says wholly owned subsidiary Zenith Energy Netherlands BV inks an extension agreement for aqcuisition of the Sidi El Kilani oilfield in Tunisia from CNPC International Tunisia Ltd, a subsidiary of NPC International Ltd. The acquisition includes the North Kairouan permit and the Sidi El Kilani concession in Tunisia. Says the completion of the acquisition still remains conditional on local authority approval.

----------

Capital Metals PLC - natural resources company focused on the development of the Eastern Minerals project in Sri Lanka - Says there is potential to increase resources at mineral sands project in Sri Lanka. Says only 10% of permits drilled but already enough resources to establish a mine. "A key benefit of mining high grade mineral sands is the potential for greatly improved economics as capital intensity is generally low. The mine size (and capex) is lower as you need to mine and process less material to produce the same amount of product," says the company.

----------

Thor Mining PLC - Australia-focused exploration and development company - Starts trading on he OTCQB market in the US, under the ticker "THORF". The OTCQB venture market is for early-stage and developing US and international companies. "We are delighted to be able to commence trading on the OTCQB platform, and to improve access for US institutional and retail investors to invest in the company and share in the growth of Thor Mining," says Chair Mick Billing.

----------

Iomart Group PLC - Glasgow-based operator of data centres - Expands network capacity "to meet future demand" with GBP2 million investment in core routing technology from Cisco Systems Inc, which will provide 100 gigabyte capacity on its network with the ability to scale to 400GB. Says the investment follows a "noticeable increase generally" in internet traffic due to Covid-19

----------

Jadestone Energy Inc - Asia Pacific-focused oil & gas company - Says company reorganisation, first announced in early February, is expected to reduce regulatory compliance burdens, resulting in estimated annual cost savings of between USD500,000 and USD1.0 million. Believes its reorganisation will "raise the company's profile and status amongst UK and European investors who are unable to invest in non-UK domiciled companies".

----------

Vast Resources PLC - mining company - Says the full executive management team are on site at the Baita Plai Polymetallic Mine in Romania to accelerate and facilitate the various aspects and workstreams involved in the development of the revised mine plan.

----------

Caledonia Mining Corp PLC - Zimbabwe-focused gold producer - Notes that it is to be included in the MVIS Global Junior Gold Miners index. The GDXJ Index forms the basis of various passive gold sector investment funds in the North American market. "I am delighted with our imminent inclusion in the GDXJ Index. The listing of our shares on the NYSE American has increased our liquidity significantly and our inclusion on the Index should further raise our profile among retail and institutional investors," says Chief Executive Steve Curtis.

----------

MetalNRG PLC - natural resource investing and exploration company - Raises GBP2.3 million, before expenses, via placing of 385.0 million shares at GBP0.006 per share. Says the shares will have warrants attached on a one for one basis with an exercise price of GBP0.01 and an exercise period of 24 months from date of issue.

----------

Intuitive Investments Group PLC - closed-end investment company focused on life sciences sector - Announces investment of GBP250,000 to acquire 416,666 shares of medical drug-device company Polarean Imaging PLC.

----------

BlueRock Diamonds PLC - South African-focused diamond miner - Notes recovery of three large gem quality stones in Kimberly, South Africa. Says the stones are 10.6 carats, 9.8 carats and 8.4 carats.

----------

Goldstone Resources Ltd - resource development company with projects in West Africa - Agrees to extend the initial term for 20 of the unsecured bonds of USD50,000 each in issue to June 15. Says the remaining six bonds have been redeemed in full through cash settlement. Paracale Gold Ltd and BCM Investments Ltd, which each own six bonds, have agreed to the extension.

----------

Red Rock Resources PLC - gold explorer in Kenya and Australia, copper-cobalt in DRC - Notes delay to May in the expected IPO of Juno Minerals Ltd, an iron ore spin-out of investee Jupiter Mines Ltd. Notes formal license grants, for Red Rock Australasia Pty Ltd joint venture with Power Metal Resources PLC, for a 60 square kilometre area called Blue Stocking and a 4 sq km area called Sardinia in the Victoria Goldfields in Australia. Both licences are for five years.

----------

Power Metal Resources PLC - exploration and development with interests in Botswana and Australia - Announces received formal license grants for a further two of its license applications for its 49%-owned joint venture with Red Rock Resources PLC, called Red Rock Australasia Pty Ltd, which is focused on gold. Says it has received formal license grants for a 60 square kilometre area called Blue Stocking and a 4 sq km area called Sardinia in the Victoria Goldfields in Australia. Both licences are for five years. Also notes "encouraging" initial airborne electromagnetic surveys recently flownover the South Ghanzi project in the Kalahari Copper Belt, Botswana. The South Ghanzi project is a joint venture with Kavango Resources PLC.

----------

Kavango Resources PLC - exploration company focused on Botswana - Sees "encouraging" initial airborne electromagnetic surveys recently flown over the company's interests in the Kalahari copper belt. These interests include the South Ghanzi project, a joint venture with Power Metal Resources PLC-, and the LVR project, a joint venture with LVR GeoExplorers Pty Ltd. "We are confident in the results we've seen so far across our various interests in the KCB. Although we are at an early stage of exploration, it is pleasing to see different early data sets correlate to one another. Over the coming months our priority remains to identify targets for drilling campaigns in the KCB later this year," says Kavango Chief Executive Michael Foster.

----------

By Greg Roxburgh; gregroxburgh@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
16 Apr 2024 20:16

TRADING UPDATES: Nexteq confident of meeting full-year expectations

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
29 Feb 2024 14:28

Polarean Imaging shares sink after announcing a costly strategic plan

(Alliance News) - Polarean Imaging PLC shares dropped on Thursday, after the company said it would need to find an additional USD10 million to finance its medium-term ambitions.

Read more
15 Jan 2024 11:21

IN BRIEF: Polarean Imaging strategic parter raises stake to above 10%

Polarean Imaging PLC - London-based developer of medical imaging devices providing magnetic resonance imaging of the lungs - Strategic partner NUKEM Isotopes GmbH buys 9.5 million Polarean shares from Amati Global Investors Ltd, raising its stake to 10.5% from 6.1%. Alzenau, Germany-based NUKEM is a trading company in stable isotopes and noble gases. Amati retains a 4.6% stake in Polarean, down from its last reported level of 9.8%. The shares purchased by NUKEM are worth GBP725,800 at Polarean's current market price.

Read more
7 Dec 2023 16:01

Polarean gets first de novo order for Xenoview polariser

(Sharecast News) - Lung-focussed MRI technology developer Polarean Imaging said in an update on Thursday that it has received its first de novo order for a new Xenoview polariser.

Read more
7 Dec 2023 12:14

IN BRIEF: Polarean shares jump on Xenoview polariser order

Polarean Imaging PLC - London-based medical imaging technology developer - Receives its first de novo order for a new Xenoview polariser from an unnamed "top-tier" academic medical centre located in the northeast of the US. Polarean says it continues to have positive meetings and is in active negotiations with additional academic medical centres. Xenoview is a hyperpolarised contrast agent for use with magnetic imaging for the evaluation of lung ventilation in adults and paediatric patients aged 12 years and older. It was approved for use in the US last year.

Read more
7 Dec 2023 11:11

AIM WINNERS & LOSERS: Smart Metering accepts offer; order for Polarean

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
8 Sep 2023 14:12

Polarean Imaging enters strategic partnership with VIDA Diagnostics

(Sharecast News) - Advanced MRI technology specialist Polarean Imaging announced a strategic partnership with a clinical imaging intelligence company VIDA Diagnostics on Friday.

Read more
8 Sep 2023 10:27

Polarean Imaging partners with Vida Diagnostics on MRI solutions

(Alliance News) - Polarean Imaging PLC on Friday said that it has partnered with Vida Diagnostics Inc to work on advanced magnetic resonance imaging solutions for the lungs.

Read more
7 Sep 2023 14:26

TRADING UPDATES: Polarean withdraws commercial targets on revenue drop

(Alliance News) - (Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
7 Sep 2023 11:20

AIM WINNERS & LOSERS: CVS plunges on CMA vet probe; Angle ascends

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
5 Sep 2023 19:42

IN BRIEF: Polarean Imaging announces code price range for Xenoview

Polarean Imaging PLC - London-based medical imaging technology developer - Announces that following statement on August 29, the reimbursement code for the Polarean Xenoview technology has been assigned to a new technology ambulatory payment classification code which corresponds to a payment range of between USD1,201 to USD1,300 as part of the 2023 medicare hospital outpatient prospective payment system final rule. Notes the codes enables healthcare providers a path to bill for "magnetic resonance imaging with inhaled hyperpolarised xenon-129 contrast agent, chest, including preparation and administration of agent."

Read more
31 Aug 2023 15:52

UK earnings, trading statements calendar - next 7 days

Friday 1 September 
Diversified Energy Co PLCHalf Year Results
Monday 4 September 
Ashtead Technology Holdings PLCHalf Year Results
Belvoir Group PLCHalf Year Results
Tuesday 5 September 
Alumasc Group PLCFull Year Results
Ashtead Group PLCQ1 Results
Blackbird PLCHalf Year Results
Craneware PLCFull Year Results
DS Smith PLCTrading Statement
Ecora Resources PLCHalf Year Results
Eurocell PLCHalf Year Results
Gamma Communications PLCHalf Year Results
GetBusy PLCHalf Year Results
Headlam Group PLCHalf Year Results
Johnson Service Group PLCHalf Year Results
Luceco PLCHalf Year Results
Michelmersh Brick Holdings PLCHalf Year Results
Midwich Group PLCHalf Year Results
Pebble Group PLCHalf Year Results
Shearwater Group PLCFull Year Results
SigmaRoc PLCHalf Year Results
STV Group PLCHalf Year Results
Tissue Regenix Group PLCHalf Year Results
Wednesday 6 September 
Apax Global Alpha LtdHalf Year Results
Ashmore Group PLCFull Year Results
Bakkavor Group PLCHalf Year Results
Barratt Developments PLCFull Year Results
Darktrace PLCFull Year Results
Halfords Group PLCTrading Statement
Hochschild Mining PLCHalf Year Results
M Winkworth PLCHalf Year Results
Malin Corp PLCHalf Year Results
Nexteq PLCHalf Year Results
Oxford Nanopore Technologies PLCHalf Year Results
Restaurant Group PLCHalf Year Results
WH Smith PLCTrading Statement
Thursday 7 September 
Angle PLCHalf Year Results
Beazley PLCHalf Year Results
Cairn Homes PLCHalf Year Results
Currys PLCTrading Statement
Direct Line Insurance Group PLCHalf Year Results
Energean PLCHalf Year Results
Funding Circle Holdings PLCHalf Year Results
Genus PLCFull Year Results
Hilton Food Group PLCHalf Year Results
Inspecs Group PLCHalf Year Results
International Public Partnerships LtdHalf Year Results
Lords Group Trading PLCHalf Year Results
Melrose Industries PLCHalf Year Results
Mpac Group PLCHalf Year Results
Playtech PLCHalf Year Results
Polarean Imaging PLCHalf Year Results
Safestore Holdings PLCTrading Statement
Synthomer PLCHalf Year Results
Vistry Group PLCHalf Year Results
WAG Payment Solutions PLCHalf Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
29 Aug 2023 14:22

Polarean's Xenoview gets US reimbursement code

(Sharecast News) - Medical device developer Polarean Imaging announced on Tuesday that its Xenoview technology has been granted a new reimbursement code by the US Centers for Medicare and Medicaid Services (CMS).

Read more
29 Aug 2023 11:36

IN BRIEF: Polarean Imaging product cleared for US Medicare payments

Polarean Imaging PLC - London-based medical imaging technology developer - Says the US Centers for Medicare & Medicaid Services has established a new reimbursement code for Polarean's Xenoview or 'xenon XE 129' magnetic resonance imaging technology. Code "enables healthcare providers a path to bill for 'magnetic resonance imaging with [the] inhaled hyperpolarised xenon-129 contrast agent...including preparation and administration of agent'." Polarean expects to be informed of the new code's payment level "in the coming weeks".

Read more
3 Aug 2023 11:31

IN BRIEF: Polarean hails US FDA approval on Philips MRI configuration

Polarean Imaging PLC - London-based medical imaging technology company - Receives 510(k) clearance from the US Food & Drug Administration for its specialised magnetic resonance imaging chest coil. The coil may now include Philips 3.0T MRI scanners for the visualisation of the Xenon-129 nuclei.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.